Abstract:Background: Fibroblast growth factor 19 (FGF19) and fibroblast growth factor receptor 4 (FGFR4) signaling play critical roles in hepatocarcinogenesis. This study explored the expression and clinical significance of FGF19/FGFR4 related signaling molecules in hepatocellular carcinoma (HCC). Method: We examined the mRNA expression of FGF19, FGFR4, klotho-beta (KLB), cyclin D1 (CCND1), and FGF4 in 151 surgically resected, primary unifocal HCC using quantitative real-time PCR analysis. The correlation of gene amplification and mRNA overexpression for FGF19 and FGF4 was investigated using a real-time PCR based copy number assay. FGF19 amplification was verified using fluorescence in situ hybridization. Univariate and multivariate analyses were performed to evaluate the prognostic value of these biomarkers for tumor recurrence and survival of patients. Results: Overexpression of FGF19, FGFR4, KLB, CCND1, and FGF4 mRNA was detected in 40%, 32%, 26%, 15%, and 35% of 151 tumors, respectively. In multivariate analyses, large tumor size (u003e 12.7 cm) and advanced tumor stage (stage ≥ II) independently predict worse patient survival. Using generalized additive models, we found mRNA expression of FGFR4 and KLB was significantly associated large tumor size (u003e 12.7 cm); mRNA expression of FGF19 and KLB was significantly associated advanced tumor stage (stage ≥ II). Furthermore, gene amplification of FGF19 and FGF4 significantly correlated to their mRNA overexpression (P = 0.006 for FGF19; P = 0.039 for FGF4). Conclusions: Overexpression of FGF19/FGFR4 related biomarkers is frequently found in HCC. Overexpression of FGF19 and FGF4 mRNA significantly correlates to their gene amplification. Expression status of FGFR4, KLB, and FGF19 may determine patient survival through their impact on tumor size (FGFR4 and KLB) and tumor stage (FGF19 and KLB). Citation Format: Zhong-Zhe Lin, Yung-Ming Jeng, Chiun Hsu, I-Lun Tsai, Kuan-Yu Chen, Fu-Chang Hu, Chih-Hung Hsu, Hey-Chi Hsu, Ann-Lii Cheng. Expression of FGF19/FGFR4 related biomarkers in hepatocellular carcinoma. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 3131.

Fucosylated Glycans Associated With Development and Metastasis of Hepatocellular Carcinoma Cells: Fucosylated Glycans Associated With Development and Metastasis of Hepatocellular Carcinoma Cells

Fucosylated Ogligosaccharides in the Migration of Hepatoma Cells

Identification and Analysis of Altered Alpha 1,6-Fucosylated Glycoproteins Associated with Hepatocellular Carcinoma Metastasis

Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT

Expression of Tumor-Invasion-related Lewis Antigens on the Surface of H7721 Human Hepatocarcinoma Cells and the Enzymatic Analysis of Their Synthesis

Introducing alpha(1,2)-linked fucose into hepatocarcinoma cells inhibits vasculogenesis and tumor growth

Lewis antigens, alpha 1,3 fucosyltransferses and the metastatic potential of human primary liver cancer

Analysis of Lewis Antigens on Cell Surface and Alpha1,3 Fucosyltransferase Subtypes in H7721 Human Hepatocarcinoma Cells.

Fucosylated Glycan Inhibition of Human Hepatocellular Carcinoma Cell Migration Through Binding to Chemokine Receptors

Alteration of Ck8 Both in Its Expression Level and Its Glycan Parts Related to Hcc Metastatic Ability

Alteration of Liver N-glycome in Patients with Hepatocellular Carcinoma

Prognostic and immunological role of alpha-L-fucosidase 2 (FUCA2) in hepatocellular carcinoma

Expression Of Fgf19/Fgfr4 Related Biomarkers In Hepatocellular Carcinoma

Overexpressed N-fucosylation on the cell surface driven by FUT3, 5, and 6 promotes cell motilities in metastatic pancreatic cancer cell lines

Glucose deprivation–induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma

Core-Fucosylated Glycoproteomics Correlated with the Metastasis of Hepatoma

The Expression of Core Fucosylated E-cadherin in Cancer Cells and Lung Cancer Patients: Prognostic Implications

Expression of SRF, E-cadherin and β-catenin in hepatocellular carcinoma and its clinical significances

FGA influences invasion and metastasis of hepatocellular carcinoma through the PI3K/AKT pathway

Fucosyltransferase 3 and 8 promote the metastatic capacity of cancer stem-like cells via CD15s and E-cadherin in esophageal cancer

Identification of Tyrosine-Phosphorylated Proteins Associated with Metastasis and Functional Analysis of FER in Human Hepatocellular Carcinoma Cells

Fucosylated Glycans Associated With Development and Metastasis of Hepatocellular Carcinoma Cells*: Fucosylated Glycans Associated With Development and Metastasis of Hepatocellular Carcinoma Cells*